Lv41
480 积分 2023-01-29 加入
Discovery of MDV6058 (PF-06952229), a selective and potent TGFβR1 inhibitor: Design, synthesis and optimization
1个月前
已完结
Simultaneous inhibition of fibroblast growth factor-2 and vascular endothelial growth factor-a with RC28-E in diabetic macular edema: a phase 2 randomised trial
2个月前
已完结
Designing of target‐specific N‐substituted tetrahydroquinoline derivatives as potent mTOR inhibitors via integrated structure‐guided computational approaches
3个月前
已关闭
The mTOR Signaling Pathway and mTOR Inhibitors in Cancer: Next-generation Inhibitors and Approaches
3个月前
已完结
Proline Analogues in Drug Design: Current Trends and Future Prospects
8个月前
已完结
Improving de novo molecular design with curriculum learning
8个月前
已完结
ICH M7指导原则下DNA反应性/致突变性杂质的控制水平
8个月前
已完结
Tautobase: An Open Tautomer Database
1年前
已完结
Tautomer Database: A Comprehensive Resource for Tautomerism Analyses
1年前
已完结
Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide (AZD5305): A PARP1–DNA Trapper with High Selectivity for PARP1 over PARP2 and Other PARPs
1年前
已完结
皖公网安备34019202002308
